Related Experiment Video
Updated: Aug 13, 2026
Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
Published on: August 23, 2024
MNDA-positive Follicular Lymphoma is a heterogeneous disease: a case series study of 19 patients
Marcos Rebollo-González1, Francisco Javier Díaz de la Pinta1, Rebeca Manso2
1Pathology Department, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Avd. Reyes Católicos-2 28040, 28040, Madrid, Spain.
Context:
Myeloid cell nuclear differentiation antigen (MNDA) is a nuclear protein involved in key cellular processes. It is expressed in 78% of marginal zone lymphomas (MZLs), but only in 2.6-19% of follicular lymphomas (FLs). The role and implications of MNDA expression in the FL context remain poorly understood.
Objective:
To characterize, for the first time, the morphological, immunophenotypic, molecular, and clinical features of MNDA-positive FLs.
Design:
We retrospectively analysed a series of 19 MNDA-expressing FLs. Histopathological features, immunohistochemistry, cytogenetic rearrangements, and mutational profiles were assessed. Clinical data, including disease grade and relapse patterns, were also reviewed.
Results:
All the 19 MNDA-positive FLs showed a follicular growth pattern, and 57.9% were low-grade. MNDA expression appeared at relapse in four initially negative cases. Marginal zone or plasmacytic differentiation was seen in 26.1% of cases. All cases were BCL6-positive; 21% were P53-positive, and 63% showed high Ki67 (> 40%). BCL2 rearrangements were found in 57.9% andBCL6 in 44.4% of the individuals. BCL2-rearranged cases had a distinct mutational profile from non-rearranged individuals. TP53mutations were present in three BCL6-rearranged cases, two of which also featured BCL2-rearrangements. Marginal/plasmacytic characteristics were not associated with specific mutations. Extra nodal recurrence occurred in 21% of cases, including one located in the colon.
Conclusion:
FLs can express MNDA, giving rise to a biologically heterogeneous subgroup of FL cases with diverse clinical, morphological, and genetic characteristics. Further studies are needed to characterize them better.
